Vectoring In — Viral Vector Video Series


When preparing to ramp up late stage manufacturing for commercialization, understanding key critical to quality parameters will help prepare your therapy for regulatory submission.

In this ‘Vectoring In’ video series, our experts will talk you through how they guide clients to prepare for regulatory submission with a focus on quality attributes.

Part 1: Avoiding CMC Delays in Cell & Gene Therapies

Discusses the impact of attention to early phase development and partnering with an experienced CDMO to prepare for regulatory submissions.

Interested in learning more? Access videos 2-4 in this series, featuring the following topics:

  • What Regulators are Looking for in Cell & Gene Therapy Submissions
  • Bypassing Late-Phase Viral Vector Process Speed Bumps
  • Accelerating Late Phase Development